The multidrug resistance protein 1: A functionally important activation marker for murine Th1 cells

Journal of Immunology

Volumn 164, Issue 2, 2000, Pages 754-761

  Prechtl, Stefan ^a   Roellinghoff, Martin ^a   Scheper, Rik ^b   Cole, Susan P C ^c   Deeley, Roger G ^c   Lohoff, Michael ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 12; MULTIDRUG RESISTANCE PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0034650332     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.2.754     Document Type: Article

References (46)

1. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229.
2. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
3. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1. Th2 and more. Immunol. Today 17:138.
4. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59.
5. Liew, F. Y.. C. Hale, and J. G. Howard. 1982. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells. J. Immunol. 128:1917.
6. Liew, F. Y., S. M. Millott, and J. A. Schmidt. 1990. A repetitive peptide of Leishmania can activate T helper type 2 cells and enhance disease progression. J. Exp. Med. 172:1359.
7. Mitchell, G. F., J. M. Curtis, E. Handman, and I. F. McKenzie. 1980. Cutaneous leishmaniasis in mice: disease patterns in reconstituted nude mice of several genotypes infected with Leishmania tropica. Aust. J. Exp. Biol. Med. Sci. 58:521.
8. Xu, D., W. L. Chan, B. P. Leung, D. Hunter, K. Schulz, R. W. Carter, I. B. McInnes, J.H. Robinson, and F. Y. Liew. 1998. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J. Exp. Med. 188:1485.
9. Xu, D., W. L. Chan, B. P. Leung, F. Huang, R. Wheeler, D. Piedrafita, J. H. Robinson, and F. Y. Lieu. 1998. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J. Exp. Med. 187:787.
10. + T cells producing Th2-type cytokines. FASEB J. 9:81.
11. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, and F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:129.
12. Loetscher, P., M. Uguccioni, L. Bordoli, M. Baggiolini, B. Moser, C. Chizzolini, and J. M. Dayer. 1998. CCR5 is characteristic of Th1 lymphocytes. Nature 391: 344.
13. Sallusto, F., D. Lenig, C. R. Mackay, and A. Lanzavecchia. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875.
14. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005.
15. Lohoff, M., S. Prechtl, F. Sommer, M. Roellinghoff, E. Schmitt, G. Gradehandt, P. Rohwer, B. D. Stride, S. P. Cole, and R. G. Deeley. 1998. A multidrug-resistance protein (MRP)-like transmembrane pump is highly expressed by resting murine T helper (Th) 2, but not Th1 cells, and is induced to equal expression levels in Th1 and Th2 cells after antigenic stimulation in vivo. J. Clin. Invest. 101:703.
16. Sommer, F., S. Bischof, M. Rollinghoff, and M. Lohoff. 1994. Demonstration of organic anion transport in T lymphocytes: L-lactate and fluo-3 are target molecules. J. Immunol. 153:3523.
17. Flens, M. J., G. J. Zaman, P. van der Valk, M. A. Izquierdo, A. B. Schroeijers, G. L. Scheffer, P. van der Groep, M. de Haas, C. J. Meijer, and R. J. Scheper. 1996. Tissue distribution of the multidrug resistance protein. Am. J. Pathol. 148: 1237.
18. Kruh, G. D., K. T. Gaughan, A. Godwin, and A. Chan. 1995. Expression pattern of MRP in human tissues and adult solid tumor cell lines. J. Natl. Cancer Inst. 87:1256.
19. Abbaszadegan, M. R., B. W. Futscher, W. T. Klimecki, A. List, and W. S. Dalton. 1994. Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res. 54:4676.
20. + T cells in experimental leishmaniasis. Infect. Immun. 56:2120.
21. Lohoff, M., E. Schmitt, K. A. Reske, and M. Rollinghoff. 1990. Different response of TH1 cells for stimulation with anti-CD3 antibodies. Eur. J. Immunol. 20:653.
22. Solbach, W., K. Forberg, E. Kammerer, C. Bogdan, and M. Rollinghoff. 1986. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice. J. Immunol. 137:702.
23. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97.
24. Flens, M. J., M. A. Izquierdo, G. L. Scheffer, J. M. Fritz, C. J. Meijer, R. J. Scheper, and G. J. Zaman. 1994. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res. 54:4557.
25. Simmons, N. L. 1990. A cultured human renal epithelioid cell line responsive to vasoactive intestinal peptide. Exp. Physiol. 75:309.
26. Cole, S. P., K. E. Sparks, K. Fraser, D. W. Loe, C. E. Grant, G. M. Wilson, and R. G. Deeley. 1994. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 54:5902.
27. Wilson, G. M., and R. G. Deeley. 1995. An episomal expression vector system for monitoring sequence-specific effects on mRNA slability in human cell lines. Plasmid 33:198.
28. Stride, B. D., G. Valdimarsson, J. H. Gerlach, G. M. Wilson, S. P. Cole, and R. G. Deeley. 1996. Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter. Mol. Pharmacol. 49:962.
29. Marrack, P., M. Blackman, E. Kushnir, and J. Kappler. 1990. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp. Med. 171: 455.
30. Heeg, K., S. Bendigs, T. Miethke, and H. Wagner. 1993. Induction of unresponsiveness to the superantigen staphylococcal enterotoxin B: cyclosporin A resistant split unresponsiveness unfolds in vivo without preceding clonal expansion. Int. Immunol. 5:929.
31. Leier, I., G. Jedlitschky, U. Buchholz, S. P. Cole, R. G. Deeley, and D. Keppler. 1994. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 269:27807.
32. Yokoyama, W. M., F. Koning, P. Kehn, G. M. Pereira, G. Stingl, J. E. Coligan, and E. M. Shevach. 1988. Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation. J. Immunol. 141:369.
33. Hipfner, D. R., S. D. Gauldie, R. G. Deeley, and S. P. Cole. 1994. Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res. 54:5788.
34. Lorico, A., G. Rappa, R. A. Finch, D. Yang, R. A. Flavell, and A. C. Sartorelli. 1997. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res. 57:5238.
35. Loe, D. W., K. C. Almquist, R. G. Deeley, and S. P. Cole. 1996. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles: demonstration of glutathione-dependent vincristine transport. J. Biol. Chem. 271:9675.
36. Muller, M., C. Meijer, G. J. Zaman, P. Borst, R. J. Scheper, N. H. Mulder, E. G. de Vries, and P. L. Jansen. 1994. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA 91:13033.
37. Keppler, D. 1992. Leukotrienes: biosynthesis, transport, inactivation, and analysis. Rev. Physiol. Biochem. Pharmacol. 121:1.
38. Wijnholds, J., R. Evers, M. R. van Leusden, C. A. Mol, G. J. Zaman, U. Mayer, J. H. Beijnen, M. van der Valk, P. Krimpenfort, and P. Borst. 1997. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat. Med. 3:1275.
39. Leier, I., G. Jedlitschky, U. Buchholz, M. Center, S. P. Cole, R. G. Deeley, and D. Keppler. 1996. ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. Biochem. J. 314:433.
40. Cole, S. P., and R. G. Deeley. 1998. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. BioEssays 20:931.
41. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
42. Stein, U., W. Walther, C. M. Laurencot, G. L. Scheffer, R. J. Scheper, and R. H. Shoemaker. 1997. Tumor necrosis factor-α and expression of the multidrug resistance-associated genes LRP and MRP. J. Natl. Cancer Inst. 89:807.
43. Raghu, G., S. W. Park, I. B. Roninson, and E. B. Mechetner. 1996. Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes. Exp. Hematol. 24:1258.
44. Barrand, M. A., K. J. Robertson, S. Y. Neo, T. Rhodes, K. A. Wright, P. R. Twentyman, and R. J. Scheper. 1995. Localisation of the multidrug resistance-associated protein. MRP, in resistant large-cell lung tumour cells. Biochem. Pharmacol. 50:1725.
45. Zaman, G. J., M. J. Flens, M. R. van Leusden, M. de Haas, H. S. Mulder, J. Lankelma, H. M. Pinedo, R. J. Scheper, F. Baas, H. J. Broxterman, et al. 1994. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. USA 91:8822.
46. Zhu, Q., H. Sun, and M. S. Center. 1997. Functional analysis of the nucleotide binding domains of the multidrug resistance protein (MRP). Oncol. Res. 9:229.